From groundbreaking findings from the UK Medical Cannabis Registry to clinical trials by the industry’s leading experts, explore the latest advancements in medical cannabis research.
Patients in the UK have had legal access to medical cannabis since November 2018. Indeed, medical cannabis is ...
Depression affects millions of people across the United Kingdom. For some, standard treatments work well. For others, finding ...
Endometriosis is a chronic inflammatory condition affecting an estimated 6% to 10% of reproductive-age women. It is characterised ...
The Netherlands is famous for its long-standing “tolerance policy” (known as gedoogbeleid), which permits the sale of small ...
Endometriosis is a chronic condition that is estimated to affect around 176 million women globally, and approximately 1 ...
Fibromyalgia is a chronic pain condition characterised by generalised pain lasting at least three months. The condition is ...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by a persistent pattern of inattention, hyperactivity-impulsivity, or both. It ...
Throughout history, the cannabis plant has been used for a wide range of therapeutic purposes, including for pain ...
Autism spectrum disorder (ASD) is a developmental brain condition that is now the ninth leading cause of neurological ...
The use of medical cannabis which includes compounds like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), is increasing, particularly among ...
For many patients, medical cannabis is a key part of managing a chronic condition. As access to prescribed ...
Mental health is a vital part of overall wellness, yet for many, accessing effective and timely care remains ...
